NBIXCommon stockNASDAQ
NBIX Common stock
This is the ticker-level security page. The issuer is Neurocrine Biosciences.
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$2.7B
Net income TTM
$428M
Total assets
$4.3B
Total debt
Not available
Total equity
$3B
Profit margin
16%
ROE
14.3%
ROA
10%
Latest issuer financial snapshot: 2024-12-31